Early research (Phase 1)Study completedNCT03015181
What this trial is testing
VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Administered Intravenously or Subcutaneously to Healthy Adults
Who this might be right for
HIV Prevention
National Institute of Allergy and Infectious Diseases (NIAID) 26